Keywords: Contrast Agent, Contrast Agent, nanoparticlesMRI is one of the best imaging techniques in clinical analysis because it is non-invasive and has high resolution. Contrast agents are used to further improve these images, as they increase the level of soft tissue detail, differentiating regions of interest. Currently, Gd-based contrast agents have important precautions. In this work we present a new nanoparticle based on iron oxide, with 4 nm and positive contrast (T1-weighted). Thus, effects similar to gadoteric acid, with reduced signal persistence and partial renal excretion, indicating great stability, this new paramagnetic nanoparticle has great potential to be applied as a contrast agent in MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords